Literature DB >> 3540317

Assignment of genes for human monoamine oxidases A and B to the X chromosome.

L M Kochersperger, E L Parker, M Siciliano, G J Darlington, R M Denney.   

Abstract

Monoclonal antibodies that immunoprecipitate human monoamine oxidase (MAO) A or human MAO B, but not the corresponding mouse enzymes, were used to assay for the presence of immunoprecipitable MAO A or MAO B (presumably coded by the respective human genes) in mouse-human hybrid somatic cell lines containing small numbers of human chromosomes. The results were as follow: Extracts of a human lymphoblastoid x mouse hepatoma hybrid line that retained the human X chromosome contained immunoprecipitable MAO B, while a similar hybrid line that contained the same human chromosomes, except for the human X, did not. Extracts of a human fibroblast x mouse neuroblastoma hybrid cell line, whose human chromosomal material consisted solely of the X, contained both immunoprecipitable MAO A and MAO B. Extracts of a related hybrid line, whose human chromosomal material consisted solely of an autonomous fragment and a fragment translocated to a mouse chromosome, contained immunoprecipitable MAO A. However, the level of immunoprecipitable MAO B activity in extracts of this hybrid was low or undetectable. Among extracts of 33 human fibroblast x mouse hepatoma hybrids that had been selected for expression of the X-linked human enzyme HPRT, 60% contained immunoprecipitable MAO B. This figure was comparable to the 58% that expressed the X-linked human isozyme for glucose-6-phosphate dehydrogenase (G6PD). When 11 of these hybrid lines, which contained immunoprecipitable MAO B and human HPRT, were selected for loss of HPRT, all lost immunoprecipitable MAO B in addition to HPRT. These data demonstrate that genes controlling the expression of MAO A and MAO B, which can be immunoprecipitated with the human-specific monoclonal antibodies, are located on the human X chromosome. Properties of the immunological epitopes recognized by the monoclonal antibodies suggest that the X-linked genes detected in this study are probably structural genes for the enzymes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3540317     DOI: 10.1002/jnr.490160403

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  17 in total

1.  Linkage analysis of Norrie disease with X-chromosomal ornithine aminotransferase.

Authors:  J B Bateman
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption.

Authors:  D W Crabb
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Potential contribution of monoamine oxidase a gene variants in ADHD and behavioral co-morbidities: scenario in eastern Indian probands.

Authors:  A Karmakar; S Maitra; D Verma; B Chakraborti; R Goswami; P Ghosh; S Sinha; K P Mohanakumar; R Usha; K Mukhopadhyay
Journal:  Neurochem Res       Date:  2014-03-21       Impact factor: 3.996

Review 4.  Why there is no gene for alcoholism.

Authors:  E J Devor
Journal:  Behav Genet       Date:  1993-03       Impact factor: 2.805

5.  Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence.

Authors:  San-Yuan Huang; Wei-Wen Lin; Fang-Jung Wan; Ai-Ju Chang; Huei-Chen Ko; Tso-Jen Wang; Pei-Lin Wu; Ru-Band Lu
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

6.  Molecular properties of monoamine oxidases A and B.

Authors:  S W Kwan; J M Bergeron; C W Abell
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Structure of the human gene for monoamine oxidase type A.

Authors:  Z Y Chen; G S Hotamisligil; J K Huang; L Wen; D Ezzeddine; N Aydin-Muderrisoglu; J F Powell; R H Huang; X O Breakefield; I Craig
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

Review 8.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

Review 9.  Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.

Authors:  M Mayersohn; T W Guentert
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

10.  Binding models of reversible inhibitors to type-B monoamine oxidase.

Authors:  Antonio Carrieri; Andrea Carotti; M Letizia Barreca; Cosimo Altomare
Journal:  J Comput Aided Mol Des       Date:  2002-11       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.